DSA
SVA

Davis Selected Advisers’s Sinovac Biotech, Ltd SVA Stock Holding History

Davis Selected Advisers’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,250,546
Closed -$7.05M – 199
2014
Q2 		$7.05M Buy
1,250,546
+6,340
+0.5% +$38.5K 0.02% 146
2014
Q1 		$8.96M Buy
1,244,206
+65,600
+6% +$434K 0.02% 126
2013
Q4 		$7.21M Sell
1,178,606
-294,737
-20% -$1.78M 0.02% 140
2013
Q3 		$8.81M Sell
1,473,343
-1,153,888
-44% -$5.52M 0.02% 128
2013
Q2 		$10.3M Buy
+2,627,231
New +$9.78M 0.03% 133

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $2.12M AUM 4.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return